Your browser doesn't support javascript.
loading
A Case of Terbinafine-Resistant Tinea Cruris Caused by Trichophyton tonsurans.
Firooz, Alireza; Lotfali, Ensieh; Fattahi, Mahsa; Fattahi, Maryam; Miramin Mohammadi, Akram; Shahrzad Kavkani, Mahshid.
Afiliação
  • Firooz A; Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, Tehran, Iran.
  • Lotfali E; Department of Medical Parasitology and Mycology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Fattahi M; Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, Tehran, Iran.
  • Fattahi M; Emergency Medicine Management Research Center, Iran University of Medical Sciences, Tehran, Iran.
  • Miramin Mohammadi A; Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, Tehran, Iran.
  • Shahrzad Kavkani M; Department of Microbial Biotechnology, Islamic Azad University, Damghan, Iran.
Case Rep Dermatol Med ; 2021: 9611072, 2021.
Article em En | MEDLINE | ID: mdl-34925922
ABSTRACT
A 26-year-old male patient referred to our center with a history of extremely itchy crusted skin lesions in his groins for one year. Moreover, his friend, a 25-year-old male, also developed similar lesions in the groin after using the shared pool, whose condition also did not improve with similar treatment. A regular mycology test (direct and culture test) was performed, as well as molecular examination. The antifungal susceptibility assay to terbinafine, itraconazole, posaconazole, fluconazole, and voriconazole was conducted according to the Clinical and Laboratory Standards Institute M38 third ed. The sequencing study identified T. tonsurans as the causative organism in both patients. The abovementioned organism isolated from both patients displayed resistance against terbinafine and fluconazole (MIC ≥ 4 µg/ml and MIC ≥ 8 µg/ml, respectively). Moreover, the susceptibility of both subjects to posaconazole (0.313 µg/ml), voriconazole (0.25-0.0625 µg/ml), and (1 µg/ml) itraconazole increased. The present report aimed to emphasize the increase in antifungal resistance and a demand for antifungal stewardship, to control this public health threat.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: En Revista: Case Rep Dermatol Med Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Irã

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: En Revista: Case Rep Dermatol Med Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Irã